The global diabetes devices market was valued at USD 20.92 billion in 2018 and is projected to reach USD 48.35 billion by 2032, reflecting a CAGR of 6.2% over the forecast period. In 2018, North America held the largest share of the market, accounting for 40.54% of the global revenue.
